Glucagon-like peptide-1 agonism - GLP-1, common in obesity medicines - is not essential to weight management, according to preclinical research led by Richard DiMarchi and Matthias Tschöp, with funding from their startup company Bluewater Biosciences.
I’m addicted to Tostito’s queso. Of course I know it’s horrible for me. At least it’ll be a queso OD, instead of “horse”.